These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1053 related articles for article (PubMed ID: 18154498)
1. Addiction and the brain antireward system. Koob GF; Le Moal M Annu Rev Psychol; 2008; 59():29-53. PubMed ID: 18154498 [TBL] [Abstract][Full Text] [Related]
2. Drug addiction, dysregulation of reward, and allostasis. Koob GF; Le Moal M Neuropsychopharmacology; 2001 Feb; 24(2):97-129. PubMed ID: 11120394 [TBL] [Abstract][Full Text] [Related]
3. Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction. Koob GF Psychopharmacology (Berl); 2017 May; 234(9-10):1315-1332. PubMed ID: 28050629 [TBL] [Abstract][Full Text] [Related]
6. Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory. Koob GF Pharmacopsychiatry; 2009 May; 42 Suppl 1(Suppl 1):S32-41. PubMed ID: 19434554 [TBL] [Abstract][Full Text] [Related]
7. Addiction and brain reward and antireward pathways. Gardner EL Adv Psychosom Med; 2011; 30():22-60. PubMed ID: 21508625 [TBL] [Abstract][Full Text] [Related]
8. Review. Neurobiological mechanisms for opponent motivational processes in addiction. Koob GF; Le Moal M Philos Trans R Soc Lond B Biol Sci; 2008 Oct; 363(1507):3113-23. PubMed ID: 18653439 [TBL] [Abstract][Full Text] [Related]
9. Neuroadaptive mechanisms of addiction: studies on the extended amygdala. Koob GF Eur Neuropsychopharmacol; 2003 Dec; 13(6):442-52. PubMed ID: 14636960 [TBL] [Abstract][Full Text] [Related]
10. Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development. Koob GF Pharmacol Rev; 2021 Jan; 73(1):163-201. PubMed ID: 33318153 [TBL] [Abstract][Full Text] [Related]
11. The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Koob GF Addiction; 2006 Sep; 101 Suppl 1():23-30. PubMed ID: 16930158 [TBL] [Abstract][Full Text] [Related]
12. Addiction as a stress surfeit disorder. Koob GF; Buck CL; Cohen A; Edwards S; Park PE; Schlosburg JE; Schmeichel B; Vendruscolo LF; Wade CL; Whitfield TW; George O Neuropharmacology; 2014 Jan; 76 Pt B(0 0):370-82. PubMed ID: 23747571 [TBL] [Abstract][Full Text] [Related]
13. Drug abuse: hedonic homeostatic dysregulation. Koob GF; Le Moal M Science; 1997 Oct; 278(5335):52-8. PubMed ID: 9311926 [TBL] [Abstract][Full Text] [Related]
15. The dark side of emotion: the addiction perspective. Koob GF Eur J Pharmacol; 2015 Apr; 753():73-87. PubMed ID: 25583178 [TBL] [Abstract][Full Text] [Related]
16. Neurobiological substrates for the dark side of compulsivity in addiction. Koob GF Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):18-31. PubMed ID: 18725236 [TBL] [Abstract][Full Text] [Related]
17. Neurobiology of addiction. Toward the development of new therapies. Koob GF Ann N Y Acad Sci; 2000; 909():170-85. PubMed ID: 10911930 [TBL] [Abstract][Full Text] [Related]
18. Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems. George O; Le Moal M; Koob GF Physiol Behav; 2012 Apr; 106(1):58-64. PubMed ID: 22108506 [TBL] [Abstract][Full Text] [Related]
19. Negative reinforcement in drug addiction: the darkness within. Koob GF Curr Opin Neurobiol; 2013 Aug; 23(4):559-63. PubMed ID: 23628232 [TBL] [Abstract][Full Text] [Related]
20. What can allostasis tell us about anabolic-androgenic steroid addiction? Hildebrandt T; Yehuda R; Alfano L Dev Psychopathol; 2011 Aug; 23(3):907-19. PubMed ID: 21756441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]